In the last 30 days, insiders at 456 Health Care companies reported 258 purchases worth $441.55M and 1,259 sales worth $2.31B. Below, the companies are ranked by how many insiders filed.
Showing companies 1 to 50 of 200 by distinct insiders filing.
| # | Ticker / Company | Insiders (30d) | Insider buys (30d) |
|---|---|---|---|
| 1 |  $ULS UL Solutions Inc. | 20 | - |
| 2 |  $KMDA KAMADA LTD | 19 | - |
| 3 |  $UNH UNITEDHEALTH GROUP INC | 15 | - |
| 4 |  $GH Guardant Health, Inc. | 13 | - |
| 5 |  $ROIV Roivant Sciences Ltd. | 12 | - |
| 6 |  $ADRX ADARx Pharmaceuticals, Inc. | 11 | $87.75M |
| 7 |  $LQDA Liquidia Corp | 11 | - |
| 8 |  $TBPH Theravance Biopharma, Inc. | 11 | - |
| 9 |  $BLFS BIOLIFE SOLUTIONS INC | 11 | - |
| 10 |  $PHVS Pharvaris N.V. | 10 | - |
| 11 |  $NBIX NEUROCRINE BIOSCIENCES INC | 10 | - |
| 12 |  $ZBH ZIMMER BIOMET HOLDINGS, INC. | 9 | - |
| 13 |  $NEOG NEOGEN CORP | 9 | $6K |
| 14 |  $MOH MOLINA HEALTHCARE, INC. | 9 | - |
| 15 |  $CALC CalciMedica, Inc. | 9 | - |
| 16 |  $ZTS Zoetis Inc. | 9 | - |
| 17 |  $RVMD Revolution Medicines, Inc. | 8 | - |
| 18 |  $LEGN Legend Biotech Corp | 8 | - |
| 19 |  $APT ALPHA PRO TECH LTD | 8 | - |
| 20 |  $RNA Atrium Therapeutics, Inc. | 8 | - |
| 21 |  $WVE Wave Life Sciences, Inc. | 8 | - |
| 22 |  $DRIO DarioHealth Corp. | 8 | - |
| 23 |  $TVTX Travere Therapeutics, Inc. | 7 | - |
| 24 |  $CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE | 7 | - |
| 25 |  $DFTX Definium Therapeutics, Inc. | 7 | - |
| 26 |  $TRXB TRex Bio, Inc. | 7 | $1.30M |
| 27 |  $OMDA Omada Health, Inc. | 7 | - |
| 28 |  $RTSN Retension Pharmaceuticals, Inc. | 7 | $370K |
| 29 |  $CBIO CRESCENT BIOPHARMA, INC. | 7 | - |
| 30 |  $MAIA MAIA Biotechnology, Inc. | 7 | $100K |
| 31 |  $PSTV PLUS THERAPEUTICS, INC. | 7 | - |
| 32 |  $PFE PFIZER INC | 7 | - |
| 33 |  $MODD Modular Medical, Inc. | 7 | - |
| 34 |  $TVGN Tevogen Inc. | 7 | - |
| 35 |  $APLM Apollomics Inc. | 7 | - |
| 36 |  $SNGX SOLIGENIX, INC. | 7 | - |
| 37 |  $GOSS Gossamer Bio, Inc. | 7 | - |
| 38 |  $TWST Twist Bioscience Corp | 6 | - |
| 39 |  $ETRA Electra Therapeutics, Inc. | 6 | $40.00M |
| 40 |  $CORT CORCEPT THERAPEUTICS INC | 6 | - |
| 41 |  $INCY INCYTE CORP | 6 | - |
| 42 |  $KURA Kura Oncology, Inc. | 6 | - |
| 43 |  $OSCR Oscar Health, Inc. | 6 | - |
| 44 |  $FENC FENNEC PHARMACEUTICALS INC. | 6 | - |
| 45 |  $BCYC BICYCLE THERAPEUTICS PLC | 6 | - |
| 46 |  $KRYS Krystal Biotech, Inc. | 6 | - |
| 47 |  $KRMD KORU Medical Systems, Inc. | 6 | - |
| 48 |  $BMY BRISTOL MYERS SQUIBB CO | 6 | - |
| 49 |  $MMED MiniMed Group, Inc. | 6 | - |
| 50 |  $VOGX Vogenx, Inc. | 6 | - |
Sales usually dwarf purchases, and that is normal, not a warning. Executives are paid in stock. They sell to diversify and to pay the tax due when awards vest, so a big sell total across a sector mostly reflects a vesting calendar. Purchases are the rarer side, because each one is an insider choosing to add to a company they already know well.
The table ranks companies by how many different insiders filed, not by dollars. That puts the cluster case near the top: several people inside one business acting in the same month. Sector placement comes from each company's SEC SIC code, mapped to the GICS sectors through a standard crosswalk, with manual fixes for well-known names the SIC code gets wrong. A single company can still land in a different sector than an index provider would give it.